Related Experiment Video
Updated: Jul 17, 2025

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Pertussis in Mexico from 2000 to 2019: A real-world study of incidence, vaccination coverage, and vaccine
Gilberto Sánchez-González1, Gerardo Luna-Casas2, Cesar Mascareñas3
1Centro de Investigación Sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Av Universidad 655, Santa María Ahuacatitlán, 62100 Cuernavaca, Morelos, Mexico.
Background:
The national immunization program in Mexico includes a 3-dose primary series of pertussis vaccine and a toddler booster dose. In Mexico, whole-cell pertussis vaccines (wP) were switched in 2007 to acellular pertussis vaccines (aP).
Methods:
This retrospective study using Mexican National Databases of Health and population surveillance (2000-2019) assessed the incidence of pertussis, infant pertussis vaccination coverage, and vaccine effectiveness (VE) against clinically-diagnosed and/or laboratory-confirmed pertussis in children aged 6.5-18.5 or 24.5 months for the primary series, and children aged 18.5 or 24.5-48.5 months for the toddler booster.
Results:
The incidence of pertussis sharply increased in 2012 and was highest in 2012, 2015, and 2016 (0.84-0.94/100,000 person-years). Coverage was highest for the first dose in the primary series, decreasing for each subsequent dose. The VE against notified pertussis was 96.4% (95% CI: 94.7, 97.6) for the first three doses of wP vaccine (2000-2007) and 95.7% (95% CI: 95.1, 96.2) for the first three doses of aP vaccine (2008-2019).
Conclusions:
Our findings suggested high levels of vaccine effectiveness overall were achieved for the aP and wP vaccines in Mexico between 2000 and 2019.
Insights
Mexico
Area of Science:
- Immunology
- Public Health
- Epidemiology
Background:
- Mexico transitioned from whole-cell pertussis (wP) to acellular pertussis (aP) vaccines in 2007.
- The national immunization program includes a primary series and a booster dose.
Purpose of the Study:
- To assess pertussis incidence, vaccination coverage, and vaccine effectiveness (VE) in Mexico from 2000-2019.
- To evaluate the impact of the vaccine switch on pertussis epidemiology.
Main Methods:
- Retrospective study utilizing Mexican National Databases of Health and population surveillance (2000-2019).
- Analysis of pertussis incidence, infant vaccination coverage, and VE in children based on age groups for primary series and booster doses.
Main Results:
- Pertussis incidence peaked in 2012, 2015, and 2016.
- Vaccine effectiveness for wP (2000-2007) was 96.4%; for aP (2008-2019) it was 95.7%.
- Coverage decreased with subsequent doses in the primary series.
Conclusions:
- Both whole-cell pertussis (wP) and acellular pertussis (aP) vaccines demonstrated high effectiveness in Mexico.
- Sustained high vaccine effectiveness is crucial for pertussis control.
More Related Videos
06:26Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
06:32Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
Related Concept Videos
Vaccinations
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Statistical Methods for Analyzing Epidemiological Data
Principles of Disease Surveillance
Microorganisms in Medicine and Therapeutics
Causality in Epidemiology